Northwest Biotherapeutics, Inc. NWBO
Set alert
0.18 USD +0.01 +3.53%
As of Nov 2, 3:59 PM ET
0.1603 Day range 0.1768
0.14 52-week range 0.34
- YTD
- -23.48%
- 1 year
- -29.60%
- Open
- 0.17
- Prev close
- 0.17
- Mkt cap
- 300.19M
- Vol
- 658.95K
- Avg vol
- 4.12M
- EPS
- -0.03
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1603
- High
- 0.1768
- Forward P/E
- 0.00
- Beta
- 0.55
- Short ratio
- 13.54
- Inst. own
- 42.60%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.407273
- 200-d avg
- 0.457338
- 1y target
- 5.00
Analyst view
Consensus: buy
Buy
Price target (mean) 5.00
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 312.62M | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 312.62M | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 312.62M | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 692.15M | +121.4% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 11, 2014 | Oppenheimer | Downgrade | Outperform | Perform |
| Oct 15, 2013 | Oppenheimer | Initiated | — | Outperform |
| Sep 18, 2013 | Summer Street Research | Initiated | — | Buy |